Status:
COMPLETED
Combined Prospective and Retrospective Post-Market Follow Up of the 'BPK-S Integration' UC as Primary Implant in the Variant CoCr
Lead Sponsor:
Peter Brehm GmbH
Collaborating Sponsors:
P.R.I.S.M.A.-CRO
Conditions:
Osteoarthritis, Knee
Joint Instability
Eligibility:
All Genders
18+ years
Brief Summary
Patients who received a total knee endoprosthesis BPK-S Integration between 2011 and 2013 will be invited to participate in this PMCF study provided sufficient source data documentation is available r...
Eligibility Criteria
Inclusion
- Patients that received a total primary knee endoprosthesis BPK-S Integration (Co28Cr6Mo) between 2011 and 2013
- Patients that agree to participate and give written informed consent to the anonymized retrospective and prospective data collection within the study
Exclusion
- No study specific exclusion criteria are defined for this PMCF study.
Key Trial Info
Start Date :
October 17 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 2 2020
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT03406637
Start Date
October 17 2018
End Date
March 2 2020
Last Update
March 6 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de Wallonie picarde - CHwapi A.S.B.L
Tournai, Belgium, 7500
2
Medical Center Tournai
Tournai, Belgium, 7500